About Protein arginine N-methyltransferase 6
Protein arginine N-methyltransferase 6 (PRMT6) is a protein
from Homo sapiens identified by UniProt accession
Q96LA8, 375 residues long.
MolForge cross-references it against 0 known binders and
133 disease associations.
Target properties
| Protein name | Protein arginine N-methyltransferase 6 |
| UniProt accession | Q96LA8 |
| Gene | PRMT6 |
| Organism | Homo sapiens |
| Length | 375 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (133)
Diseases linked to this target (Open Targets).
- sex hormone-binding globulin measurement · score 0.46
- testosterone measurement · score 0.43
- bilirubin measurement · score 0.42
- serum gamma-glutamyl transferase measurement · score 0.42
- lean body mass · score 0.42
- Red cell distribution width · score 0.41
- body fat percentage · score 0.41
- low density lipoprotein cholesterol measurement · score 0.40
- body mass index · score 0.40
- cystatin C measurement · score 0.38
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q96LA8-F1 | alphafold | PREDICTED | 93.45 | — |
Amino-acid sequence (375 residues)
MSQPKKRKLE SGGGGEGGEG TEEEDGAERE AALERPRRTK RERDQLYYEC YSDVSVHEEM IADRVRTDAY RLGILRNWAA LRGKTVLDVG AGTGILSIFC AQAGARRVYA VEASAIWQQA REVVRFNGLE DRVHVLPGPV ETVELPEQVD AIVSEWMGYG LLHESMLSSV LHARTKWLKE GGLLLPASAE LFIAPISDQM LEWRLGFWSQ VKQHYGVDMS CLEGFATRCL MGHSEIVVQG LSGEDVLARP QRFAQLELSR AGLEQELEAG VGGRFRCSCY GSAPMHGFAI WFQVTFPGGE SEKPLVLSTS PFHPATHWKQ ALLYLNEPVQ VEQDTDVSGE ITLLPSRDNP RRLRVLLRYK VGDQEEKTKD FAMED
Explore Protein arginine N-methyltransferase 6 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets